Sign in
4

Changes in Ownership

Karyopharm Therapeutics Inc. Filed Acc 0001209191-22-060041

President and CEO sold 3,490 shares at $5.17 ($18,043)

From the SEC's structured data for this filing

Trades in this filing

Table I: Non-derivative

Insider Date Transaction Shares Price Value Owned after D/I
Paulson Richard A. President and CEO 2022-12-05 Sale −3,490 $5.17 $18,043 612,527 D: show line 1 in the form
Open-market sales · 3,490 sh · avg $5.17 · $18,043
Loading xslF345X03/doc4.xml…